Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119

被引:28
作者
Darout, Etzer [5 ,6 ,7 ,8 ]
Robinson, Ralph P. [1 ,2 ,3 ,4 ]
McClure, Kim F. [5 ,6 ,7 ,8 ]
Corbett, Matthew [1 ,2 ,3 ,4 ]
Li, Bryan [1 ,2 ,3 ,4 ]
Shavnya, Andrei [1 ,2 ,3 ,4 ]
Andrews, Melissa P. [1 ,2 ,3 ,4 ]
Jones, Christopher S. [1 ,2 ,3 ,4 ]
Li, Qifang [1 ,2 ,3 ,4 ]
Minich, Martha L. [1 ,2 ,3 ,4 ]
Mascitti, Vincent [1 ,2 ,3 ,4 ]
Guimaraes, Cristiano R. W. [5 ,6 ,7 ,8 ]
Munchhof, Michael J. [1 ,2 ,3 ,4 ]
Bahnck, Kevin B. [1 ,2 ,3 ,4 ]
Cai, Cuiman [1 ,2 ,3 ,4 ]
Price, David A. [5 ,6 ,7 ,8 ]
Liras, Spiros [5 ,6 ,7 ,8 ]
Bonin, Paul D. [1 ,2 ,3 ,4 ]
Cornelius, Peter [1 ,2 ,3 ,4 ]
Wang, Ruduan [1 ,2 ,3 ,4 ]
Bagdasarian, Victoria [1 ,2 ,3 ,4 ]
Sobota, Colleen P. [1 ,2 ,3 ,4 ]
Hornby, Sam [1 ,2 ,3 ,4 ]
Masterson, Victoria M. [1 ,2 ,3 ,4 ]
Joseph, Reena M. [1 ,2 ,3 ,4 ]
Kalgutkar, Amit S. [5 ,6 ,7 ,8 ]
Chen, Yue [1 ,2 ,3 ,4 ]
机构
[1] Pfizer Worldwide Res & Dev, Dept Med Chem, Groton, CT 06340 USA
[2] Pfizer Worldwide Res & Dev, Dept Discovery Biol, Groton, CT 06340 USA
[3] Pfizer Worldwide Res & Dev, Dept Drug Metab, Groton, CT 06340 USA
[4] Pfizer Worldwide Res & Dev, Dept Pharmaceut Sci, Groton, CT 06340 USA
[5] Pfizer Worldwide Res & Dev, Dept Med Chem, Cambridge, MA 02139 USA
[6] Pfizer Worldwide Res & Dev, Dept Discovery Biol, Cambridge, MA 02139 USA
[7] Pfizer Worldwide Res & Dev, Dept Drug Metab, Cambridge, MA 02139 USA
[8] Pfizer Worldwide Res & Dev, Dept Pharmaceut Sci, Cambridge, MA 02139 USA
关键词
4-AMINO-2-PHENYLPYRIMIDINE DERIVATIVES; GPR119; AGONISTS; DISCOVERY; SERIES; EFFICIENCY; POTENT; OPTIMIZATION; SAFETY; ACID; LEAD;
D O I
10.1021/jm301626p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1 similar to 3,7,similar to]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the diazatricyclic ring system, which was achieved using a Hofmann-Loffler-Freytag reaction as the key step. The basis for the use of this complex framework lies in an attempt to constrain one end of the molecule in the "agonist conformation" as was previously described for 3-oxa-7-aza-bicyclo[3.3.1]nonanes. Optimization of carbamate analogues of the diazatricylic compounds led to the identification of 32i as a potent agonist of the GPR119 receptor with low unbound human liver microsomal clearance. The use of an agonist response weighted ligand lipophilic efficiency (LLE) termed AgLLE is discussed along with the issues of applying efficiency measures to agonist programs. Ultimately, solubility limited absorption and poor exposure reduced further interest in these molecules.
引用
收藏
页码:301 / 319
页数:19
相关论文
共 50 条
[1]  
[Anonymous], 2011, Diabetes fact sheet No. 312
[2]   N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (σ) receptor ligands [J].
Banister, Samuel D. ;
Yoo, David T. ;
Chua, Sook Wern ;
Cui, Jinquan ;
Mach, Robert H. ;
Kassiou, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) :5289-5292
[3]   A modified palladium catalysed reductive amination procedure [J].
Berdini, V ;
Cesta, MC ;
Curti, R ;
D'Anniballe, G ;
Di Bello, N ;
Nano, G ;
Nicolini, L ;
Topai, A ;
Allegretti, M .
TETRAHEDRON, 2002, 58 (28) :5669-5674
[4]   Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus [J].
Briones, Mariele ;
Bajaj, Mandeep .
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) :1055-1064
[5]   Discovery, optimisation and in vivo evaluation of novel GPR119 agonists [J].
Brocklehurst, Katy J. ;
Broo, Anders ;
Butlin, Roger J. ;
Brown, Hayley S. ;
Clarke, David S. ;
Davidsson, Ojvind ;
Goldberg, Kristin ;
Groombridge, Sam D. ;
Kelly, Elizabeth E. ;
Leach, Andrew ;
McKerrecher, Darren ;
O'Donnell, Charles ;
Poucher, Simon ;
Schofield, Paul ;
Scott, James S. ;
Teague, Joanne ;
Westgate, Leanne ;
Wood, Matt J. M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) :7310-7316
[6]   SGLT2 inhibition - a novel strategy for diabetes treatment [J].
Chao, Edward C. ;
Henry, Robert R. .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (07) :551-559
[7]   Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu [J].
Curatolo, William ;
Nightingale, James A. ;
Herbig, Scott M. .
PHARMACEUTICAL RESEARCH, 2009, 26 (06) :1419-1431
[8]   From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus [J].
DeFronzo, Ralph A. .
DIABETES, 2009, 58 (04) :773-795
[9]   Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience [J].
Derosa, Giuseppe ;
Maffioli, Pamela .
DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (04) :350-364
[10]   THE SIGNIFICANCE OF GPR119 AGONISTS AS A FUTURE TREATMENT FOR TYPE 2 DIABETES [J].
Dhayal, Shalinee ;
Morgan, Noel G. .
DRUG NEWS & PERSPECTIVES, 2010, 23 (07) :418-424